| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/10/1999 | CA2312464A1 Oral antioxidant preparation comprising selenium and reduced glutathione |
| 06/10/1999 | CA2312290A1 Secreted proteins and polynucleotides encoding them |
| 06/10/1999 | CA2312195A1 Low-voltage activated calcium channel compositions and methods |
| 06/10/1999 | CA2312191A1 Threonine-containing protegrins |
| 06/10/1999 | CA2312043A1 Mixed lipopeptide micelles for inducing an immune response |
| 06/10/1999 | CA2312009A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| 06/10/1999 | CA2312007A1 Methods and means for inducing apoptosis by interfering with bip-like proteins |
| 06/10/1999 | CA2312002A1 Human rnase h and compositions and uses thereof |
| 06/10/1999 | CA2311930A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances |
| 06/10/1999 | CA2311780A1 Porous hydroxyapatite particles as carriers for drug substances |
| 06/10/1999 | CA2311768A1 Inhibition of nuclear import by backbone cyclic peptide analogs |
| 06/10/1999 | CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 06/10/1999 | CA2311633A1 Compositions of leukaemia inhibitory factor |
| 06/10/1999 | CA2311615A1 Conjugates useful in the treatment of prostate cancer |
| 06/10/1999 | CA2311613A1 Chemoprotective bacterial strains |
| 06/10/1999 | CA2311611A1 Molecules interacting with apoptin |
| 06/10/1999 | CA2311574A1 Cells expressing anti-fc receptor binding components |
| 06/10/1999 | CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening |
| 06/10/1999 | CA2309810A1 Erythropoietin with high specific activity |
| 06/10/1999 | CA2309806A1 Hydrophobically-modified protein compositions and methods |
| 06/10/1999 | CA2309534A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 06/10/1999 | CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/09/1999 | EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene |
| 06/09/1999 | EP0921195A1 Antisense base sequences |
| 06/09/1999 | EP0921194A2 TRAILLK-2: a member of the TNF ligand family |
| 06/09/1999 | EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
| 06/09/1999 | EP0921192A1 Molecules interacting with apoptin |
| 06/09/1999 | EP0921132A1 Novel human receptor type tyrosine kinase-like protein |
| 06/09/1999 | EP0921131A1 Chemically modified polypeptides |
| 06/09/1999 | EP0920873A2 Stabilized teriparatide solutions |
| 06/09/1999 | EP0920843A1 Drug delivery system |
| 06/09/1999 | EP0920630A2 Prion protein binding proteins and uses thereof |
| 06/09/1999 | EP0920534A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA ($g(a)), HNF-1$g(b) AND HNF-4$g(a) |
| 06/09/1999 | EP0920524A1 A short-shafted adenoviral fiber and its use |
| 06/09/1999 | EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome |
| 06/09/1999 | EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME |
| 06/09/1999 | EP0920514A1 Targeting adenovirus with use of constrained peptide motifs |
| 06/09/1999 | EP0920513A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF MORAXELLA CATARRHALIS |
| 06/09/1999 | EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 06/09/1999 | EP0920511A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
| 06/09/1999 | EP0920509A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 06/09/1999 | EP0920508A1 HUMAN POLYHOMEOTIC 1 ($i(hph1)) ACTS AS AN ONCOGENE |
| 06/09/1999 | EP0920507A2 Secreted proteins and polynucleotides encoding them |
| 06/09/1999 | EP0920506A1 Human dbi/acbp-like protein |
| 06/09/1999 | EP0920505A1 Mammalian cell surface antigens; related reagents |
| 06/09/1999 | EP0920504A2 Voltage-gated calcium channel antagonist and methods |
| 06/09/1999 | EP0920503A2 A novel human leptin receptor gene-related protein |
| 06/09/1999 | EP0920502A1 Methods and means for modifying complement activation |
| 06/09/1999 | EP0920501A1 Neuritin, a neurogene |
| 06/09/1999 | EP0920500A1 Human proteolipid |
| 06/09/1999 | EP0920499A2 Polynucleotides encoding secreted proteins |
| 06/09/1999 | EP0920494A2 Pro-protein converting enzyme |
| 06/09/1999 | EP0920492A1 Dendritic cells produced in serum-free culture |
| 06/09/1999 | EP0920452A1 Novel osteopontin derived chemotactic peptides and methods of use |
| 06/09/1999 | EP0920451A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| 06/09/1999 | EP0920448A1 Truncated glial cell line-derived neurotrophic factor |
| 06/09/1999 | EP0920447A1 Process of purification of cyclosporin |
| 06/09/1999 | EP0920446A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 06/09/1999 | EP0920445A1 Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions |
| 06/09/1999 | EP0920444A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 06/09/1999 | EP0920443A1 Activated peptides and conjugates |
| 06/09/1999 | EP0920335A1 Use of proteolytic enzymes for preventing or treating graft rejection |
| 06/09/1999 | EP0920334A1 Use of proteolytic enzymes for treating septic shock |
| 06/09/1999 | EP0920333A1 Induction of tolerance by proteases |
| 06/09/1999 | EP0920332A1 Use of at least one proteolytic enzyme for treating glomerulonephritis |
| 06/09/1999 | EP0920331A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 06/09/1999 | EP0920330A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS |
| 06/09/1999 | EP0920329A1 Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets |
| 06/09/1999 | EP0920328A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 06/09/1999 | EP0920327A1 Enhancement of antimicrobial peptide activity by metal ions |
| 06/09/1999 | EP0920326A1 Antithrombotic materials and methods |
| 06/09/1999 | EP0920325A2 Tetrapeptide derivatives of dolastatin as antitumor agents |
| 06/09/1999 | EP0920324A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| 06/09/1999 | EP0920305A1 Identification of genes altered in multiple myeloma |
| 06/09/1999 | EP0839045A4 Interleukin-1 receptor-associated protein kinase and assays |
| 06/09/1999 | EP0661986B1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 06/09/1999 | EP0620740B1 Injectable lecithin gel |
| 06/09/1999 | CN1219175A Zona pellucida proteins for contraception |
| 06/09/1999 | CN1219174A Inhibitors of protein farnesyl transferase |
| 06/09/1999 | CN1219134A Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy |
| 06/09/1999 | CN1219133A Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 06/09/1999 | CN1218833A Polypeptide with cell withering promoting activity |
| 06/09/1999 | CN1218813A Method for preparing medicine using silkworm produced recombined human thrombocytopoietic factor |
| 06/09/1999 | CN1218812A Method for preparing medicine using silkworm expressed recombined human erythropoietin |
| 06/09/1999 | CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
| 06/09/1999 | CN1218690A Polypeptide oral liquor |
| 06/09/1999 | CN1218671A Nutritive liquid for nourishing brain and promoting intelligence growth |
| 06/08/1999 | US5910583 Antisense oligonucleotides against ERBB-2 |
| 06/08/1999 | US5910581 Polypeptides of glycosaminoglycan sulfotransferase originating from human and DNA coding for the polypeptides |
| 06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
| 06/08/1999 | US5910573 Monomeric and dimeric antibody-fragment fusion proteins |
| 06/08/1999 | US5910568 Molecule involved in binding of sperm to egg surfaces and procedures for use of this molecule to enhance or decrease potential fertility |
| 06/08/1999 | US5910513 Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions |
| 06/08/1999 | US5910488 Plasmids suitable for gene therapy |
| 06/08/1999 | US5910483 Drug for treatment of growth related disorders, gastrointstinal tract diseases, anorexia nervosa and mammary cancer |
| 06/08/1999 | US5910482 Effective treating pregnancy disorder and premature labor in a pregnant female mammal |
| 06/08/1999 | US5910481 Hybrid proteins with modified activity |
| 06/08/1999 | US5910480 (early placenta insulin-like peptide) molecule of the insulin family; induces dna synthesis, tyrosine phosphorylation |
| 06/08/1999 | US5910479 Administering lanthocin antimicrobial in excess of minimal inhibitory concentration |
| 06/08/1999 | US5910478 Peptidomimetics inhibiting the oncogenic action of p21 ras |